Regenerative medicine clinical readiness.
Satsuki YamadaAtta BehfarAndre TerzicPublished in: Regenerative medicine (2021)
Regenerative medicine, poised to transform 21st century healthcare, has aspired to enrich care options by bringing cures to patients in need. Science-driven responsible and regulated translation of innovative technology has enabled the launch of previously unimaginable care pathways adopted prudently for select serious diseases and disabilities. The collective resolve to advance the design, manufacture and validity of affordable regenerative solutions aims to democratize such health benefits for all. The objective of this Review is to outline the framework and prerequisites that underpin clinical readiness of regenerative care. Integrated research and development, specialized workforce education and accessible evidence-based practice implementation are at the core of realizing an equitable regenerative medicine vision.
Keyphrases
- healthcare
- quality improvement
- palliative care
- stem cells
- public health
- mesenchymal stem cells
- end stage renal disease
- cell therapy
- ejection fraction
- affordable care act
- newly diagnosed
- chronic kidney disease
- primary care
- prognostic factors
- mental health
- pain management
- climate change
- patient reported outcomes
- health insurance